Ben N. is a seasoned professional in CMC Analytical Development and Biologics, currently serving at AbbVie since April 2025. Prior experience includes positions at Bristol Myers Squibb from June 2022 to April 2025 as Principal Scientist and Biotherapeutics Quality Attributes Team Lead, where Ben managed the biotherapeutics quality attributes group and advanced analytics for various biologics. From June 2017 to June 2022, Ben held roles at AstraZeneca, leading analytical development programs, managing teams, and driving analytical strategies while demonstrating success in improving project efficiency. Ben earned a Ph.D. in Mass Spectrometry, Biochemistry, and Bioinformatics from Washington University in St. Louis and a Master of Data Analytics from the University of Maryland Global Campus.
This person is not in any teams
This person is not in any offices